SPI Pharma has been solving formulation challenges using superior functional materials.
Please Wait
Applying Filters...
01 8Evonik
02 1SPI Pharma
03 2Aeon Procare
04 16BASF
05 15Corel Pharma Chem
06 3Ideal Cures
07 1Kerry
08 1Sigachi Industries
09 3The Dow Chemical Company
SPI Pharma has been solving formulation challenges using superior functional materials.
Dosage Form : Tablet
Grade : Oral
Application : Coating Systems & Additives, Controlled & Modified Release
Excipient Details : ACTILLETS are microcrystalline cellulose spheres developed using advanced drug delivery technology to enable effective loading & coating of particles.
Pharmacopoeia Ref : NA
Technical Specs :
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Tablet
Grade : Oral
SPI Pharma has been solving formulation challenges using superior functional materials.
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Tablet
Category : Coating Systems & Additives, Controlled & Modified Release
Brand : ACTILLETS™
Pharmacopoeia Ref : NA
Technical Specs : Not Available
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100 (powder), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® RL 100 (granules) is an excipient used as a solubilizer in combination with Eudragit® RS for creating sustained release drugs.
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Ammonia Methacrylate Copolymer Type A
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® RL 100
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® RS, a functional sustained release polymer, used in combination with EUDRAGIT® RL for customized release profiles in tablets, capsules, etc.
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Ammonio Methacrylate Copolymer Type B
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® RS 100
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® S 100, a delayed release polymer can be combined with other polymers for precise targeting and rapid drug release in tablets, capsules, etc.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer 1:2
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer 1:2
Category : Controlled & Modified Release
Brand : EUDRAGIT® S 100
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
